The PennZone

  • Home
  • Education
  • Non-profit
  • Technology
  • Construction
  • Health
  • Entertainment
  • Marketing
  • Business

Remix Therapeutics™ Appoints Maria Koehler, M.D., Ph.D., as an Independent Board Director
The PennZone/10273802

Trending...
  • Philadelphia's Own Reverend Jamie Knight Returns with "Award-Winning Love
  • Kolbus Introduces the Next Step in Casemaking Efficiency
  • Heavy Duty Journal Surpasses 1000 Technical Articles for Diesel Technicians and Fleet Managers
WATERTOWN, Mass., June 18, 2024 ~ Remix Therapeutics, a clinical-stage biotechnology company, has recently announced the appointment of Dr. Maria Koehler as an independent director to their Board of Directors. This move comes as Remix continues to develop small molecule therapies that target RNA processing and address the underlying causes of various diseases.

According to Peter Smith, Ph.D., Co-Founder and Chief Executive Officer of Remix, Dr. Koehler's extensive industry knowledge and experience will be invaluable as the company advances its pipeline of RNA processing modulators. This includes their lead program REM-422, which is a first-in-class therapy.

Dr. Koehler brings over 20 years of experience in leading clinical and regulatory strategy operations for biotech and pharmaceutical companies focused on oncology research and development. She currently serves as the Chief Medical Officer at Repare Therapeutics, a clinical-stage precision oncology company. In addition, she has held executive and medical leadership roles at Pfizer, AstraZeneca, Bicycle Therapeutics, and GlaxoSmithKline.

More on The PennZone
  • ET&T Adds Senior Technical Voice Engineer to Strengthen Local Team
  • Stepping Off the Grid: Savista Retreat Announces New Experiential Packages in Jaipur for Travellers
  • Where Is Your Faith The Movie and Sountrack
  • Bynn Intelligence Ranks #1 in NIST Child Online Safety Evaluation for Ages 13–16
  • Rev-O-Box™ Launches Reversible Shipping Box That Instantly Becomes a Premium Gift Box

Dr. Koehler's expertise also extends to academia, where she has served as the clinical director of Bone Marrow Transplantation at University Hospital in Pittsburgh and as the director of the Bone Marrow Transplant Program at St. Christopher's Hospital in Philadelphia. She is a board-certified hematology/oncology physician with an M.D. and Ph.D. from the Silesian School of Medicine in Katowice, Poland.

Currently serving as an independent director on the boards of Ikena Oncology and Abdera Therapeutics, Dr. Koehler expressed her excitement about joining Remix during this pivotal time for the company. She believes that their innovative approach to reprogramming RNA processing holds great therapeutic potential and looks forward to working with Remix leadership and fellow board members to drive this science forward.

With Dr. Koehler's appointment, Remix is poised for success as they continue to make strides in developing groundbreaking therapies that target RNA processing. The company is confident that her expertise and guidance will be instrumental in their journey towards improving the lives of patients with various diseases.
Filed Under: Business

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Everything Policy Launches Madison, an AI Tool That Makes Legislation Readable for Students and Citizens
  • Is the Market Missing One of the Most Undervalued Cybersecurity Companies on the Stock Market? Cycurion, Inc. (N A S D A Q: CYCU):
  • Billion-Dollar Scale Global Technology Powerhouse Being Built with Expanding Government Contracts: Circle8 Group (N A S D A Q: CIRC)
  • Nevada Boxing Hall of Fame Gears Up for Star-Studded 14th Annual Induction Gala Weekend
  • MedSocially Expands Access to Healthcare Networking Platform
  • New Thriller 'Counterframe' Explores the Hidden Vulnerabilities of Modern Society
  • Award-Winning Heritage at South Brunswick Continues to Thrive as One of New Jersey's Premier New Home Communities
  • Four Seasons Cleaners Debuts Santa Barbara County's First 24/7 Dry Cleaning Kiosk New self-service
  • WhereTu Launches to Help Americans Build Successful Lives Abroad
  • Alcom Printing Achieves SGP Recertification
  • John Marc Rittle Receives Pennsylvania's Most Influential Leaders Award
  • Appliance EMT Expands Built-In and Walk-In Refrigerator Service in Metro Atlanta
  • LawProactive Launches SB 37-Compliant Attorney Marketing Software With Exclusive City Territories Across California
  • Cogs and Marvel expands EMEA leadership team for next phase of growth
  • Beat the Philly Heat: Mid-July AC Boost
  • Dave Freer's "Storm-Dragon" Wins First-Ever Prometheus Special Award For Young Adult Fiction
  • T. Jones Group Celebrates Two Wins and Multiple Project Nominations at the 2026 HAVAN Awards
  • Studica Robotics Supports Robotics Training Camp for WorldSkills Shanghai 2026
  • Lineus Medical Renews Agreement with Vizient, Delivering Enhanced Value for Vizient Members
  • Pittsburgh Divorce Attorney Candice L. Komar Elected Chair of PBA Family Law Section

Popular on PennZone

  • ReviewsAlly Launches Evidence-Based Review Platform for VPNs, Business Software, and Online Services - 103
  • Top 5 Most Reliable Used Vans in the UK in 2026
  • Sylvester Anthony III Introduces His Artist Journey with Debut Single "Cherish"
  • Together We Thrive: Kingdom Life Health & Career Fair Unites Faith, Wellness and Opportunity
  • Compton to host first Juneteenth celebration with We Are Us Festival
  • Proper Sky Named to the 2026 MSP 501
  • Week 47 Final Freedom Vigil at Alligator Alcatraz: Truth Out
  • What Happens When Congress Says No? New Book Examines the Boland Amendments, Iran-Contra Affair & Jamaican Posse, as US Congress Debate Over Military
  • Christmas Miracle Chronicles - New movie coming up this holiday season !
  • Psychiatric Hospitals Fail to Warn Electroshock Patients of FDA-Cited Risks in Estimated $7 Billion Industry

Similar on PennZone

  • Northeast Airlines Launches New Asset Management Group
  • AI Visibility Labs LLC - Dallas Texas - July 16 2026
  • NextBoat's AI-Powered Marine Marketplace Gains Momentum as Record Growth Signals an Inflection Point for Investors (N Y S E American: NXB)
  • Bynn Intelligence Ranks #1 in NIST Child Online Safety Evaluation for Ages 13–16
  • Pacto Medical Wins Red Dot Design Concept Award 2026 for Slimshot® Compact Prefilled Syringe
  • Is the Market Missing One of the Most Undervalued Cybersecurity Companies on the Stock Market? Cycurion, Inc. (N A S D A Q: CYCU):
  • Billion-Dollar Scale Global Technology Powerhouse Being Built with Expanding Government Contracts: Circle8 Group (N A S D A Q: CIRC)
  • Alcom Printing Achieves SGP Recertification
  • Appliance EMT Expands Built-In and Walk-In Refrigerator Service in Metro Atlanta
  • Cogs and Marvel expands EMEA leadership team for next phase of growth
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us